| 1 |
Mbatha LS, Akinyelu J, Chukwuma CI, Mokoena MP, Kudanga T. Current Trends and Prospects for Application of Green Synthesized Metal Nanoparticles in Cancer and COVID-19 Therapies. Viruses 2023;15:741. [DOI: 10.3390/v15030741] [Reference Citation Analysis]
|
| 2 |
Liu Z, Han Z, Jin X, An J, Kim J, Chen W, Kim JS, Zheng J, Deng J. Regulating the microenvironment with nanomaterials: Potential strategies to ameliorate COVID-19. Acta Pharm Sin B 2023. [PMID: 36846153 DOI: 10.1016/j.apsb.2023.02.010] [Reference Citation Analysis]
|
| 3 |
Shi Y, Chen L, Zhu M, Zhao Y. The Future of Nanomedicine. Nanomedicine 2023. [DOI: 10.1007/978-981-16-8984-0_24] [Reference Citation Analysis]
|
| 4 |
Shehu IA, Musa MK, Datta A, Verma A. Application of Nanotechnology in COVID-19 Infection: Findings and Limitations. JNT 2022;3:203-232. [DOI: 10.3390/jnt3040014] [Reference Citation Analysis]
|
| 5 |
Fontana F, Gelain F. Modeling of supramolecular biopolymers: Leading the in silico revolution of tissue engineering and nanomedicine. Nanotechnology Reviews 2022;11:2965-2996. [DOI: 10.1515/ntrev-2022-0455] [Reference Citation Analysis]
|
| 6 |
Wittmann C. DNA Immobilization. Encyclopedia of Analytical Chemistry 2022. [DOI: 10.1002/9780470027318.a9210.pub2] [Reference Citation Analysis]
|
| 7 |
Cao M, Zhang K, Zhang S, Wang Y, Chen C. Advanced Light Source Analytical Techniques for Exploring the Biological Behavior and Fate of Nanomedicines. ACS Cent Sci . [DOI: 10.1021/acscentsci.2c00680] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 8 |
Wilson B, Mukundan Geetha K. Nanomedicine to deliver biological macromolecules for treating COVID-19. Vaccine 2022;40:3931-41. [PMID: 35660038 DOI: 10.1016/j.vaccine.2022.05.068] [Reference Citation Analysis]
|
| 9 |
Domingues C, Santos A, Alvarez-Lorenzo C, Concheiro A, Jarak I, Veiga F, Barbosa I, Dourado M, Figueiras A. Where Is Nano Today and Where Is It Headed? A Review of Nanomedicine and the Dilemma of Nanotoxicology. ACS Nano 2022. [PMID: 35729778 DOI: 10.1021/acsnano.2c00128] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 10 |
Kianpour M, Akbarian M, Uversky VN. Nanoparticles for Coronavirus Control. Nanomaterials (Basel) 2022;12:1602. [PMID: 35564311 DOI: 10.3390/nano12091602] [Reference Citation Analysis]
|
| 11 |
Rodríguez-Izquierdo I, Sepúlveda-Crespo D, Lasso JM, Resino S, Muñoz-Fernández MÁ. Baseline and time-updated factors in preclinical development of anionic dendrimers as successful anti-HIV-1 vaginal microbicides. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2022;14:e1774. [PMID: 35018739 DOI: 10.1002/wnan.1774] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Alqosaibi AI. Nanocarriers for anticancer drugs: challenges and perspectives. Saudi Journal of Biological Sciences 2022. [DOI: 10.1016/j.sjbs.2022.103298] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Jafari A, Danesh Pouya F, Niknam Z, Abdollahpour-Alitappeh M, Rezaei-Tavirani M, Rasmi Y. Current advances and challenges in COVID-19 vaccine development: from conventional vaccines to next-generation vaccine platforms. Mol Biol Rep 2022. [PMID: 35235159 DOI: 10.1007/s11033-022-07132-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 14 |
Alphandéry E. Nano dimensions/adjuvants in COVID-19 vaccines. J Mater Chem B 2022. [PMID: 35166754 DOI: 10.1039/d1tb02408f] [Reference Citation Analysis]
|
| 15 |
Morgulchik N, Athanasopoulou F, Chu E, Lam Y, Kamaly N. Potential therapeutic approaches for targeted inhibition of inflammatory cytokines following COVID-19 infection-induced cytokine storm. Interface Focus 2022;12:20210006. [PMID: 34956607 DOI: 10.1098/rsfs.2021.0006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 16 |
Feng T, Nie C, Peng P, Lu H, Wang T, Li P, Huang W. Nanoagent-based theranostic strategies against human coronaviruses. Nano Res 2022;15:3323-37. [PMID: 35003529 DOI: 10.1007/s12274-021-3949-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 17 |
Shi Y, Chen L, Zhu M, Zhao Y. The Future of Nanomedicine. Nanomedicine 2022. [DOI: 10.1007/978-981-13-9374-7_24-1] [Reference Citation Analysis]
|
| 18 |
Bharathan BP, Rajagopal R, Alfarhan A, Arasu MV, Al-dhabi NA. Advancement in Nanomaterial Synthesis and its Biomedical Applications. Nanotechnology in the Life Sciences 2022. [DOI: 10.1007/978-3-030-80371-1_14] [Reference Citation Analysis]
|
| 19 |
Huang S, Zhu Y, Zhang L, Zhang Z. Recent Advances in Delivery Systems for Genetic and Other Novel Vaccines. Adv Mater 2021;:e2107946. [PMID: 34914144 DOI: 10.1002/adma.202107946] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 20 |
Patel M, Patel R, Rai M. Nanomedicines. Nanotechnology in Medicine 2021. [DOI: 10.1002/9781119769897.ch1] [Reference Citation Analysis]
|
| 21 |
M. Lepkowsky C. COVID-19, Telehealth and Access to Care. SARS-CoV-2 Origin and COVID-19 Pandemic Across the Globe 2021. [DOI: 10.5772/intechopen.99300] [Reference Citation Analysis]
|
| 22 |
Rauf MA, Tasleem M, Bhise K, Tatiparti K, Sau S, Iyer AK. Nano-therapeutic strategies to target coronavirus. View (Beijing) 2021;2:20200155. [PMID: 34766165 DOI: 10.1002/VIW.20200155] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 23 |
Jermy BR, Ravinayagam V, Almohazey D, Alamoudi WA, Dafalla H, Akhtar S, Tanimu G. PEGylated green halloysite/spinel ferrite nanocomposites for pH sensitive delivery of dexamethasone: A potential pulmonary drug delivery treatment option for COVID-19. Appl Clay Sci 2021;:106333. [PMID: 34776567 DOI: 10.1016/j.clay.2021.106333] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 24 |
Brain D, Plant-Hately A, Heaton B, Arshad U, David C, Hedrich C, Owen A, Liptrott NJ. Drug delivery systems as immunomodulators for therapy of infectious disease: Relevance to COVID-19. Adv Drug Deliv Rev 2021;178:113848. [PMID: 34182016 DOI: 10.1016/j.addr.2021.113848] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 25 |
Woźniak E, Tyczewska A. Bioeconomy during the COVID-19 and perspectives for the post-pandemic world: Example from EU. EFB Bioeconomy Journal 2021;1:100013. [DOI: 10.1016/j.bioeco.2021.100013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 26 |
Yang X, You J, Wei Y, Li H, Gao L, Guo Q, Huang Y, Gong C, Yi C. Emerging nanomaterials applied for tackling the COVID-19 cytokine storm. J Mater Chem B 2021;9:8185-201. [PMID: 34528037 DOI: 10.1039/d1tb01446c] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 27 |
Sa-Nguanmoo N, Namdee K, Khongkow M, Ruktanonchai U, Zhao Y, Liang XJ. Review: Development of SARS-CoV-2 immuno-enhanced COVID-19 vaccines with nano-platform. Nano Res 2021;:1-30. [PMID: 34659650 DOI: 10.1007/s12274-021-3832-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 28 |
Liu H, Zhong W, Zhang X, Lin D, Wu J. Nanomedicine as a promising strategy for the theranostics of infectious diseases. J Mater Chem B 2021;9:7878-908. [PMID: 34611689 DOI: 10.1039/d1tb01316e] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 29 |
Tammam SN, El Safy S, Ramadan S, Arjune S, Krakor E, Mathur S. Repurpose but also (nano)-reformulate! The potential role of nanomedicine in the battle against SARS-CoV2. J Control Release 2021;337:258-84. [PMID: 34293319 DOI: 10.1016/j.jconrel.2021.07.028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 30 |
Kashapov RR, Kashapova NE, Ziganshina AY, Syakaev VV, Khutoryanskiy VV, Zakharova LY. Interaction of mucin with viologen and acetate derivatives of calix[4]resorcinols. Colloids Surf B Biointerfaces 2021;208:112089. [PMID: 34500201 DOI: 10.1016/j.colsurfb.2021.112089] [Reference Citation Analysis]
|
| 31 |
Zare M, Thomas V, Ramakrishna S. Nanoscience and quantum science-led biocidal and antiviral strategies. J Mater Chem B 2021. [PMID: 34378553 DOI: 10.1039/d0tb02639e] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 32 |
Guo W, Lakshminarayanan H, Rodriguez-Palacios A, Salata RA, Xu K, Draz MS. Glycan Nanostructures of Human Coronaviruses. Int J Nanomedicine 2021;16:4813-30. [PMID: 34290504 DOI: 10.2147/IJN.S302516] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 33 |
Ruseska I, Fresacher K, Petschacher C, Zimmer A. Use of Protamine in Nanopharmaceuticals-A Review. Nanomaterials (Basel) 2021;11:1508. [PMID: 34200384 DOI: 10.3390/nano11061508] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 34 |
Serag E, El-zeftawy M. Environmental aspect and applications of nanotechnology to eliminate COVID-19 epidemiology risk. Nanotechnol Environ Eng 2021;6:11. [DOI: 10.1007/s41204-021-00108-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 35 |
Rana MM. Polymer-based nano-therapies to combat COVID-19 related respiratory injury: progress, prospects, and challenges. J Biomater Sci Polym Ed 2021;32:1219-49. [PMID: 33787467 DOI: 10.1080/09205063.2021.1909412] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 36 |
Cai Y, Tang C, Wei Z, Song C, Zou H, Zhang G, Ran J, Han W. Fused-Ring Small-Molecule-Based Bathochromic Nano-agents for Tumor NIR-II Fluorescence Imaging-Guided Photothermal/Photodynamic Therapy. ACS Appl Bio Mater 2021;4:1942-9. [DOI: 10.1021/acsabm.0c01576] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 37 |
Bonam SR, Kotla NG, Bohara RA, Rochev Y, Webster TJ, Bayry J. Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary infections. Nano Today 2021;36:101051. [PMID: 33519949 DOI: 10.1016/j.nantod.2020.101051] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 13.7] [Reference Citation Analysis]
|
